Familial hypercholesterolaemia
KEYWORDS: people, diagnosis, quality, statement, data, treatment, testing, clinical, children, specialist, hypercholesterolaemia, familial hypercholesterolaemia, clinical diagnosis, familial, source

Quality statements Statement 1 Adults with a baseline total cholesterol above 7.5 mmol/l are assessed for a clinical diagnosis of familial hypercholesterolaemia (FH). Statement 2 People with a clinical diagnosis of FH are referred for specialist assessment. Statement 3 People with a clinical diagnosis of FH are offered DNA testing as part of a specialist assessment. Statement 4 Children at risk of FH are offered diagnostic tests by the age of 10 years. Statement 5 Relatives of people with a confirmed diagnosis of monogenic FH are offered DNA testing through a nationwide, systematic cascade process. Statement 6 Adults with FH receive lipid-modifying drug treatment to reduce LDL-C concentration by more than 50% from baseline. Statement 7 Children with FH are assessed for lipid-modifying drug treatment by a specialist with expertise in FH in a child-focused setting by the age of 10 years. Statement 8 People with FH are offered a structured review at least annually. Quality statement 1: Diagnosis Quality statement Adults with a baseline total cholesterol above 7.5 mmol/l are assessed for a clinical diagnosis of familial hypercholesterolaemia (FH). Rationale Most of the 120,000 people estimated to have FH are undiagnosed and untreated. Because untreated FH carries a very
